Molekule Group Stock EBITDA
Molekule Group fundamentals help investors to digest information that contributes to Molekule's financial success or failures. It also enables traders to predict the movement of Molekule Stock. The fundamental analysis module provides a way to measure Molekule's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Molekule stock.
Molekule |
Molekule Group Company EBITDA Analysis
Molekule's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Molekule EBITDA | 8.34 M |
Most of Molekule's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Molekule Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Molekule Group reported earnings before interest,tax, depreciation and amortization of 8.34 M. This is 98.57% lower than that of the Machinery sector and 67.16% lower than that of the Industrials industry. The ebitda for all United States stocks is 99.79% higher than that of the company.
Molekule EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Molekule's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Molekule could also be used in its relative valuation, which is a method of valuing Molekule by comparing valuation metrics of similar companies.Molekule is currently under evaluation in ebitda category among its peers.
Molekule Fundamentals
| Return On Equity | -1.17 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (1.53) % | |||
| Operating Margin | (1.47) % | |||
| Current Valuation | 45.01 M | |||
| Shares Outstanding | 34.65 M | |||
| Shares Owned By Insiders | 33.02 % | |||
| Shares Owned By Institutions | 30.70 % | |||
| Number Of Shares Shorted | 775.6 K | |||
| Revenue | 48.03 M | |||
| Gross Profit | 277.62 K | |||
| EBITDA | 8.34 M | |||
| Net Income | (1.55 M) | |||
| Total Debt | 46.72 M | |||
| Book Value Per Share | 1.20 X | |||
| Cash Flow From Operations | (41.28 M) | |||
| Short Ratio | 0.78 X | |||
| Earnings Per Share | (0.68) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 91 | |||
| Market Capitalization | 1.87 M | |||
| Total Asset | 52.32 M | |||
| Retained Earnings | (7.92 M) | |||
| Working Capital | 20.22 M | |||
| Z Score | 1.72 | |||
| Net Asset | 52.32 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Molekule Stock
If you are still planning to invest in Molekule Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molekule's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |